Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. HAEMATO AG
  6. Summary
    HAE   DE000A289VU3

HAEMATO AG

(HAE)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
24.2 24.2 24.4 24.5 24.4 Last
816 455 3952 1309 339 Volume
-0.82% 0.00% +0.83% +0.41% -0.41% Change
Estimated financial data (e)
Sales 2021 294 M 343 M 343 M
Net income 2021 8,61 M 10,0 M 10,0 M
Net Debt 2021 5,01 M 5,84 M 5,84 M
P/E ratio 2021 11,5x
Yield 2021 4,17%
Sales 2022 327 M 380 M 380 M
Net income 2022 9,35 M 10,9 M 10,9 M
Net Debt 2022 2,72 M 3,17 M 3,17 M
P/E ratio 2022 13,6x
Yield 2022 4,71%
Capitalization 128 M 148 M 148 M
EV / Sales 2021 0,45x
EV / Sales 2022 0,40x
Nbr of Employees 147
Free-Float 99,7%
More Financials
Company
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan.... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Ratings of HAEMATO AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about HAEMATO AG
09/20PRESS RELEASE : M1 Kliniken AG continues growth course
DJ
09/08HAEMATO AG (VON FIRST BERLIN EQUITY : Buy
DJ
08/11HAEMATO AG Provides Earnings Guidance for the Year 2021
CI
07/30Haemato Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
07/16PRESS RELEASE : M1 Kliniken AG successfully held its Annual General Meeting 2021
DJ
06/04ORIGINAL-RESEARCH : HAEMATO AG (von First Berlin Equity Research GmbH): Buy
DJ
06/02PRESS RELEASE : MPH Health Care AG: result Q1-2021
DJ
05/31HAEMATO : Q1 2020 results
PU
05/31PRESS RELEASE : HAEMATO AG with strong start to the year: EBIT rises in Q1 by 350 % to EUR..
DJ
05/31HAEMATO AG WITH STRONG START TO THE : EBIT rises in Q1 by 350 % to EUR 2.4 million and re..
EQ
05/26Haemato Ag Reports Earnings Results for the Full Year Ended December 31, 2020
CI
04/27PRESS RELEASE : M1 Kliniken AG publishes preliminary figures for the 2020 financial year: ..
DJ
04/21HAEMATO : According to the preliminary IFRS financial statements for the 2020 financial ye..
PU
04/21HAEMATO : According to the preliminary IFRS financial statements for the 2020 financial ye..
EQ
04/21PRESS RELEASE : According to the preliminary IFRS financial statements for the 2020 financ..
DJ
More news
News in other languages on HAEMATO AG
09/20M1 Kliniken AG setzt Wachstumskurs entschlossen fort
09/08HAEMATO AG (VON FIRST BERLIN EQUITY : Buy
09/08HAEMATO AG (VON GBC AG) : Kaufen
09/08HAEMATO AG (VON GBC AG) : Kaufen
07/16DGAP-NEWS : M1 Kliniken AG führt erfolgreich ihre ordentliche Hauptversammlung 2021 durch
More news
Chart HAEMATO AG
Duration : Period :
HAEMATO AG Technical Analysis Chart | HAE | DE000A289VU3 | MarketScreener
Technical analysis trends HAEMATO AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 24,40 €
Average target price 47,70 €
Spread / Average Target 95,5%
EPS Revisions
Managers and Directors
Patrick Brenske Chief Executive Officer
Andrea Grosse Chairman-Supervisory Board
Sabine Meck Deputy Chairman-Supervisory Board
Marion Braun Member-Supervisory Board
Sector and Competitors